Ebb Therapeutics
company
About
Ebb Therapeutics develops regional cerebral thermal therapy (RCTT) device for use in insomnia and sleep disorders.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $38M
- Industries
- Genetics,Health Care,Life Science,Medical,Medical Device,Therapeutics
- Founded date
- Jan 1, 2008
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Ebb Therapeutics develops regional cerebral thermal therapy (RCTT) device for use in insomnia and sleep disorders. It offers Ebb Insomnia Therapy, a drug-free insomnia therapy.
Eric Nofzinger founded Cereve in 2008 that later became Ebb Therapeutics. aIts headquarters in Pittsburgh in Pennsylvania.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$38M
Ebb Therapeutics has raised a total of
$38M
in funding over 2 rounds. Their latest funding was raised on
Jan 5, 2017 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 5, 2017 | Series B | $38M | 2 |
Kohlberg Kravis Roberts
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Ebb Therapeutics is funded by 2 investors.
Kohlberg Kravis Roberts
and Versant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Kohlberg Kravis Roberts
|
Yes | Series B |
Versant Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
